GoKawiilWendy's rejects Peltz's $1.4B buyout bid, adopts poison pill
Wendy's independent directors unanimously rejected a $1.4 billion buyout offer from activist investor Nelson Peltz, saying it undervalues the company. The board also adopted a one-year shareholder rights plan that triggers discounted stock purchases for other shareholders if any party's stake hits 15%; Peltz's Trian Fund Management already owns 16.3% of shares.
GoKawiil's interpretation of the reporting above, not reported fact.
The poison pill signals Wendy's board intends to resist pressure from its largest shareholder while CEO Bob Wright, newly arrived from Potbelly, pushes his own turnaround plan. Peltz's push comes as Wendy's has lost market share to rivals and faces inflation-pressured consumers, which could fuel further shareholder tension if performance doesn't improve quickly.
- Wendy's board unanimously rejected Peltz's $1.4 billion offer as undervaluing the company
- A one-year poison pill blocks any shareholder from exceeding a 15% stake without triggering discounted share sales
- Wendy's U.S. burger market share fell from 11.5% in 2019 to 10.4% last year, per Technomic
Source: entrepreneur.com — Jonathan Small, 2026-11-06
Published there as: “Wendy’s Turns Down $1.4 Billion Buyout and Adopts a ‘Poison Pill’ Defense to Block a Takeover”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.